New publication!
Jared Snider
SegueTx-Pancreatic Cancer is excited about the recent publication by the founder and members of his laboratory at LSUHSC entitled The Arf-like GTPase Arl8b is essential for three-dimensional invasive growth of prostate cancer in vitro and xenograft formation and growth in vivo. This article appears in OncoTarget, volume 7, number 21.
This paper adds to the growing body of data validating lysosome trafficking as a good cancer therapeutic target and adds value to the repurposed drugs discovered that prevent lysosome exocytosis and inhibit tumor cell invasion.